SciDev Ltd (ASX:SDV): MaxiFlox Contracts Extend Water Treatment Supply Across Key Sectors

Aditi Sarkar

28 October 2026 06:06 PM AEDT

SciDev Ltd (ASX:SDV): MaxiFlox Contracts Extend Water Treatment Supply Across Key Sectors

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Three MaxiFlox supply contracts have a combined committed value of about $8 million.
Customer extension options could add an estimated $4 million, but are not guaranteed.
Contracts cover a Hunter Valley coal operation, municipal water services and infrastructure.
The company expects about $5 million of the committed value to be recognised during FY27.
Contract execution, timing and customer extension decisions remain key variables.

SciDev Ltd (ASX:SDV) develops and supplies water treatment chemistry and engineered solutions for industrial, mining, infrastructure and utility applications. Its MaxiFlox formulations support separation and treatment processes, while OptiFlox technology helps manage chemical dosing. On 28 October 2026, the company disclosed three new chemistry supply contracts spanning different end markets, providing further detail on its contracted work and expected revenue recognition.

How the New Contracts Are Structured

The three awards have a combined committed value of approximately $8 million, according to SciDev Ltd (ASX:SDV). Their initial durations range from roughly one to three years. Additional customer-controlled extension options are estimated at $4 million, which would increase the potential aggregate value to about $12 million if all were exercised. The optional amount is not part of the committed total.

One agreement covers flocculant and coagulant chemistry supplied to a Hunter Valley coal operation under a two-year term. A second involves a major municipal water and wastewater provider and begins with a three-year MaxiFlox flocculant contract that includes extension options. The third covers a national infrastructure project, with chemistry supply over a period of up to 18 months.

SciDev Ltd (ASX:SDV) did not identify the three customers in its announcement. It stated that all contracts were secured through competitive tender processes. The packages combine its MaxiFlox chemistry with OptiFlox automated dosing technology and site-based technical support, although specific supply volumes and pricing arrangements for each contract were not disclosed.

Committed Value Versus Future Revenue

Of the approximately $8 million committed value, SciDev Ltd (ASX:SDV) expects around $5 million to be recognised as revenue in FY27. It described about $3 million of that amount as incremental relative to FY26. The remainder is associated with subsequent periods across the relevant contract terms. These amounts are company expectations, not revenue already recorded.

The company did not disclose individual contract margins, precise start dates, delivery volumes or termination conditions. Recognition will depend on supply and service performance under each agreement. Similarly, the additional $4 million attached to extension options would become relevant only if customers elected to continue on the applicable terms.

SciDev Ltd (ASX:SDV) also said recurring revenue accounted for 38% of total FY26 revenue. It identified approximately $14 million of new chemistry contracts announced in calendar 2026, including a previously announced $6 million contract associated with a gold operation at Boddington. The latest $8 million of committed awards forms part of that reported annual total, rather than an addition to it.

What the Sector Mix Indicates

The three customer groups use water treatment chemistry in different operating settings. Mining facilities require treatment of process streams and slurry, municipal providers manage water and wastewater services, and major infrastructure projects can require chemical treatment over defined construction periods. The contracts therefore extend SciDev Ltd (ASX:SDV) across several applications without establishing how revenue will be divided among those customers.

The company also referred to its Rum Jungle project, with completion expected in the first half of FY27. No further project financial metrics were included in the supplied announcement. The announcement focuses on contracted values and delivery periods, not an earnings outlook.

Key Insights

SciDev Ltd (ASX:SDV) has disclosed three distinct chemistry contracts worth about $8 million on a committed basis. The proposed extensions, estimated at another $4 million, remain contingent on customer decisions. The distinction matters because announced contracts, optional work and recognised revenue represent different stages of commercial activity. The FY27 revenue expectation provides a timing reference, while margins and volumes remain undisclosed.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.